Investing Profile

Vincent Brichard

Investor
Senior Vice-president at GlaxoSmithKline Biologicals
Brussels
Photo of Vincent Brichard, Investor
Your Intro Paths to Vincent Brichard

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Vincent Brichard on

cb
Current Investing Position
Investor
Investment Range
$1M - $5.0M
Sweet Spot
$1.5M
Investments On Record
8

Vincent Brichard is on these Sector & Stage Rankings

Vincent Brichard's Investments On Record (5)

CompanyStageDateRound SizeTotal Raised
FoRx Therapeutics
Series ADec 2025$50M
Series AJun 2025$49M
SeedApr 2020$11M
$110M
Co-investors: Florian Müllershausen (Novartis Venture Fund), Therese Liechtenstein (M Ventures (Merck)), Denis Patrick (Pfizer Venture Investments), Vincent Ossipow (Omega Funds)
ATB Therapeutics
Series ANov 2024$57M
$57M
Co-investors: John de Koning (EQT Life Sciences)
Minervax
Series UnknownOct 2023$57M
$140M
Co-investors: Kabeer Aziz (Adjuvant Capital), Christopher Gagliardi (Sanofi Ventures), Veronica Gambillara Fonck (Pureos Bioventures)
ImCheck Therapeutics
Series CJun 2022$100M
Series BDec 2019$53M
$180M
Co-investors: Klaus Breiner (Pureos Bioventures), Rémi Droller (Kurma Partners), Michael Baran (Pfizer Venture Investments), Dr. Regina Hodits (Wellington Partners), Raphael Wisniewski (Andera Partners), Florent Gros (Earlybird Venture Capital)
Egle Therapeutics
Series AOct 2021$47M
$47M
Co-investors: Felice Verduyn - van Weegen (EQT Life Sciences), Jacques Mizrahi (Bioqube Ventures)

Vincent Brichard's Experience

Venture Partner EQT Life Sciences2016 - 2022

Founders who looked at Vincent Brichard's profile also looked at these Scouts & Angels

Photo of Satya Patel, General Partner at Homebrew

Homebrew